Bart‐Jan Kroesen

4.6k total citations · 1 hit paper
75 papers, 3.6k citations indexed

About

Bart‐Jan Kroesen is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Bart‐Jan Kroesen has authored 75 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 33 papers in Immunology and 21 papers in Cancer Research. Recurrent topics in Bart‐Jan Kroesen's work include Immune Cell Function and Interaction (17 papers), MicroRNA in disease regulation (16 papers) and T-cell and B-cell Immunology (14 papers). Bart‐Jan Kroesen is often cited by papers focused on Immune Cell Function and Interaction (17 papers), MicroRNA in disease regulation (16 papers) and T-cell and B-cell Immunology (14 papers). Bart‐Jan Kroesen collaborates with scholars based in Netherlands, United States and Germany. Bart‐Jan Kroesen's co-authors include Anke van den Berg, Joost Kluiver, Sibrand Poppema, Debora de Jong, S. Jacobs, Tjasso Blokzijl, Izabella Ślęzak-Prochazka, Geert Harms, Elisabeth Brouwer and Yusuf A. Hannun and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Blood.

In The Last Decade

Bart‐Jan Kroesen

73 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas

2005 548 citations Joost Kluiver, Sibrand Poppema et al. The Journal of Pathology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bart‐Jan Kroesen Netherlands	31	2.4k	1.6k	852	454	253	75	3.6k
Claire M. Dubois Canada	33	1.7k 0.7×	738 0.5×	764 0.9×	643 1.4×	214 0.8×	83	3.8k
Akihiko Muto Japan	35	2.9k 1.2×	502 0.3×	1.6k 1.9×	548 1.2×	189 0.7×	80	4.5k
Qingguo Ruan United States	28	1.4k 0.6×	1.2k 0.7×	1.7k 2.0×	406 0.9×	192 0.8×	58	3.3k
Stefan Masure Belgium	26	1.0k 0.4×	1.4k 0.8×	582 0.7×	701 1.5×	107 0.4×	37	2.8k
Jin‐Xin Bei China	31	1.6k 0.6×	879 0.5×	1.1k 1.3×	1.4k 3.0×	189 0.7×	87	3.7k
Deborah L. Galson United States	35	2.3k 0.9×	802 0.5×	1.0k 1.2×	1.4k 3.2×	184 0.7×	83	3.9k
Philip H. Howe United States	46	3.7k 1.5×	1.1k 0.7×	788 0.9×	1.6k 3.4×	276 1.1×	104	5.2k
Karl N. Miller United States	19	2.1k 0.9×	588 0.4×	715 0.8×	688 1.5×	280 1.1×	24	3.8k
Huijie Bian China	32	2.2k 0.9×	1.0k 0.6×	882 1.0×	698 1.5×	463 1.8×	108	3.7k

Countries citing papers authored by Bart‐Jan Kroesen

Since Specialization

Citations

This map shows the geographic impact of Bart‐Jan Kroesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart‐Jan Kroesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart‐Jan Kroesen more than expected).

Fields of papers citing papers by Bart‐Jan Kroesen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart‐Jan Kroesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart‐Jan Kroesen. The network helps show where Bart‐Jan Kroesen may publish in the future.

Co-authorship network of co-authors of Bart‐Jan Kroesen

This figure shows the co-authorship network connecting the top 25 collaborators of Bart‐Jan Kroesen. A scholar is included among the top collaborators of Bart‐Jan Kroesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart‐Jan Kroesen. Bart‐Jan Kroesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vledder, Annegé, Nienke van Rooij, Annechien Plat, et al.. (2025). Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial. Clinical Cancer Research. 31(6). 1016–1026. 4 indexed citations

Bungener, Laura, et al.. (2024). HLA‐B*51:197: A composite product of interlocus recombination of B*51:01:01:01 and C*01:02:01:01. HLA. 104(1). e15606–e15606. 2 indexed citations

Bijzet, Johan, Ewout J. Houwerzijl, Friso L. H. Muntinghe, et al.. (2024). High-Sensitivity Cardiac Troponin T to Exclude Cardiac Involvement in TTR Variant Carriers and ATTRv Amyloidosis Patients. Journal of Clinical Medicine. 13(3). 810–810. 2 indexed citations

Abdulahad, Wayel H., Abraham Rutgers, Birgitta I. Hiddinga, et al.. (2024). Baseline Blood CD8+ T Cell Activation Potency Discriminates Responders from Non-Responders to Immune Checkpoint Inhibition Combined with Stereotactic Radiotherapy in Non-Small-Cell Lung Cancer. Cancers. 16(14). 2592–2592. 1 indexed citations

Bröckelmann, Paul J., Lydia Visser, Conrad‐Amadeus Voltin, et al.. (2024). Serum TARC Dynamics Correlate with Clinical Response and Metabolic Tumor Volume during Anti-PD1-Based First-Line HL Treatment in the GHSG Phase II Nivahl Trial. Blood. 144(Supplement 1). 3044–3044. 1 indexed citations

Lukens, Michaël V., Joyce Curvers, Caroline Roozendaal, et al.. (2020). Comparison of different immunoassays for the detection of antibodies against Intrinsic Factor and Parietal Cells. Journal of Immunological Methods. 487. 112867–112867. 7 indexed citations

Bijma, Theo, Pytrick Jellema, Anke van den Berg, et al.. (2019). Increased miR-142-3p Expression Might Explain Reduced Regulatory T Cell Function in Granulomatosis With Polyangiitis. Frontiers in Immunology. 10. 2170–2170. 22 indexed citations

Geest, Kornelis S. M. van der, Bart‐Jan Kroesen, Gerda Horst, et al.. (2018). Impact of Aging on the Frequency, Phenotype, and Function of CD161-Expressing T Cells. Frontiers in Immunology. 9. 752–752. 26 indexed citations

Chalan, Paulina, Johan Bijzet, Bart‐Jan Kroesen, Annemieke M. H. Boots, & Elisabeth Brouwer. (2016). Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis Are Associated with Autoantibody Status. The Journal of Rheumatology. 43(6). 1008–1016. 39 indexed citations

10.

Chalan, Paulina, Johan Bijzet, Anke van den Berg, et al.. (2016). Analysis of serum immune markers in seropositive and seronegative rheumatoid arthritis and in high-risk seropositive arthralgia patients. Scientific Reports. 6(1). 26021–26021. 39 indexed citations

11.

Chalan, Paulina, Johan Bijzet, Minke G. Huitema, et al.. (2015). Expression of Lectin-Like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis. PLoS ONE. 10(7). e0132436–e0132436. 14 indexed citations

12.

Teteloshvili, Nato, Katarzyna Smigielska‐Czepiel, Bart‐Jan Kroesen, et al.. (2015). T-cell Activation Induces Dynamic Changes in miRNA Expression Patterns in CD4 and CD8 T-cell Subsets. MicroRNA. 4(2). 117–122. 26 indexed citations

13.

Geest, Kornelis S. M. van der, Wayel H. Abdulahad, Gerda Horst, et al.. (2015). Quantifying Distribution of Flow Cytometric TCR-Vβ Usage with Economic Statistics. PLoS ONE. 10(4). e0125373–e0125373. 23 indexed citations

14.

Kluiver, Joost, Johan H. Gibcus, Nancy Halsema, et al.. (2012). Rapid Generation of MicroRNA Sponges for MicroRNA Inhibition. PLoS ONE. 7(1). e29275–e29275. 115 indexed citations

15.

Gibcus, Johan H., Bart‐Jan Kroesen, Roelof Koster, et al.. (2011). MiR‐17/106b seed family regulates p21 in Hodgkin's lymphoma. The Journal of Pathology. 225(4). 609–617. 32 indexed citations

16.

Stel, Alja J., Bart‐Jan Kroesen, S. Jacobs, et al.. (2004). The Role of B Cell-Mediated T Cell Costimulation in the Efficacy of the T Cell Retargeting Bispecific Antibody BIS20x3. The Journal of Immunology. 173(10). 6009–6016. 2 indexed citations

17.

Kroesen, Bart‐Jan, S. Jacobs, Benjamin J. Pettus, et al.. (2003). BcR-induced Apoptosis Involves Differential Regulation of C16 and C24-Ceramide Formation and Sphingolipid-dependent Activation of the Proteasome. Journal of Biological Chemistry. 278(17). 14723–14731. 96 indexed citations

18.

Kroesen, Bart‐Jan, D.Th. Sleijfer, Grietje Molema, et al.. (1997). Approaches to lung cancer treatment using the CD3E×GP-2-directed Bispecific Monoclonal Antibody BIS-1. Cancer Immunology Immunotherapy. 45(3-4). 203–206. 27 indexed citations

19.

Kroesen, Bart‐Jan, René A. J. Janssen, Jan Buter, et al.. (1995). Bispecific Monoclonal Antibodies for Intravenous Treatment of Carcinoma Patients: Immunobiologic Aspects. Journal of Hematotherapy. 4(5). 409–414. 9 indexed citations

20.

Kroesen, Bart‐Jan, et al.. (1992). Direct visualisation and quantification of cellular cytotoxicity using two colour fluorescence. Journal of Immunological Methods. 156(1). 47–54. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact